breast cancer

Women who experience primary ovarian insufficiency (menopause before the age of 40) are more than twice as likely to experience breast cancer as other women of similar ages. The study, published in the Journal of Clinical Endocrinology and Metabolism, 12…

In Africa, women's infertility carries a heavy stigma; it becomes their label. Many end up feeling worthless, face harsh treatment from in-laws, abandonment by spouses, or relegation to polygamous marriages, as husbands take additional wives capable of bearing children. For…

Just 30 minutes of exercise increases the proportion of tumour-killing immune cells in the blood of people with breast cancer. The Finnish study, published in Frontiers in Immunology, 24 June, found that the proportion of CD8+ T cells and natural…

A combination of existing drugs may inhibit development of bone metastasis in breast cancer patients. The study published in Cancer Discovery, 1 March, found that a combined treatment strategy that activates T cells while at the same time targeting cells…

It all started with a high school friendship. Anna Szołucha, a photographer who specialises in noir-style black-and-white female nudes, read a post by her high school friend Agnieszka Ford on social media. Agnieszka wrote that she was in a medical…

Components of flaxseed may help to prevent the development of breast cancer. The mouse study, published in Microbiology Spectrum, 7 December 2023, uncovers a novel link between flaxseed consumption in the diet, the gut microbiota and microRNAs in the breast…

Women who regularly attend breast screening mammography have a reduced risk of breast cancer mortality. The Swedish study, Abstract R1-SSBR10, presented at the annual meeting of the Radiological Society of North America (RSNA), held in Chicago, Illinois, 26–30 November, found…

Women living in US neighbourhoods with higher levels of ‘walkability’ have lower risks of obesity related cancers, including postmenopausal breast, endometrial, ovarian, and multiple myeloma. The prospective study, published in Environmental Health Perspectives, 10 October, found women living in neighbourhoods…

Every year, around 2.3 million people across the globe are diagnosed with breast cancer. For lack of access to the right diagnostic test, many of them are being treated with chemotherapy that is doing them more harm than good –…

Adding the CDK4/6 inhibitor ribociclib to standard-of-care adjuvant endocrine therapy for treatment of hormone receptor-positive HER2-negative early-stage breast cancer reduced risk of recurrence by 25%. The phase III NATALEE study, abstract LBA500, presented at the ASCO 2023 Annual Meeting, held…